Skip to main content

Duodenogastric reflux-induced (alkaline) esophagitis

Current Treatment Options in Gastroenterology volume 7, pages 53–58 (2004)Cite this article

Opinion statement

Duodenogastric reflux is the retrograde flow of duodenal contents into the stomach that then mix with acid and pepsin. These agents can reflux into the esophagus (ie, duodenogastroesophageal reflux [DGER]) and cause gastroesophageal reflux disease (GERD) and its complications, including stricture, Barrett’s esophagus, and adenocarcinoma of the esophagus. Medical and surgical treatments of DGER can be difficult. Best medical treatment is proton-pump inhibitors, which decrease DGER by inhibiting both gastric acidity and volume, making less gastric contents available to reflux into the esophagus. The addition of the gamma-aminobutyric (GABAB) recepto agonist baclofen may further reduce DGER in patients not responding to proton-pump inhibitors. Bile acid-binding agents (aluminum-containing antacids, cholestyramine, sucralfate, urosodeoxycholic acid) have physiologic rationale, but their efficacy is unproven. Prokinetic agents can reduce DGER and its upper gastrointestinal symptoms by promoting increased gastric emptying. In patients with medically refractory symptoms, a Roux-en-Y diversion or duodenal switch operation may be helpful.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References and Recommended Reading

  1. Schidlbeck NE, Heinrich C, Stellard F, et al.: Healthy controls have as much bile reflux as gastric ulcer patients. Gut 1987, 88:1577–1583.

    Google Scholar 

  2. Vaezi MF, Singh S, Richter JE: Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995, 108:1897–1907.

    PubMed  Article  CAS  Google Scholar 

  3. Champion G, Richter JE, Vaezi MF, et al.: Duodenogstroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology 1994, 107:747–754.

    PubMed  CAS  Google Scholar 

  4. Attwood SE, Ball CS, Barlow AP, et al.: Role of intragastric and intraesophageal alkalinization in the genesis of complications in Barrett’s columnar lined lower esophagus. Gut 1993, 34:11–15.

    PubMed  CAS  Google Scholar 

  5. Harmon JW, Johnson LF, Maydonvitch CL: Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 1981, 26:65–72.

    PubMed  Article  CAS  Google Scholar 

  6. Helsinger N: Oesophagitis following total gastrectomy: a follow-up study in 9 patients 5 years or more after operation. Acta Chir Scand 1959, 118:190–201.

    Google Scholar 

  7. Orlando RC, Bozymski EM: Heartburn in pernicious anemia—a consequence of bile reflux. N Engl J Med 1973, 289:522–523.

    PubMed  CAS  Article  Google Scholar 

  8. Pellegrini CA, DeMeester TR, Wernly JA, et al.: Alkaline gastroesophageal reflux. Am J Surg 1978, 135:177–184.

    PubMed  Article  CAS  Google Scholar 

  9. De Vault KR, Georgeson S, Castell DO: Salivary stimulation mimics esophageal exposure to refluxed duodenal contents. Am J Gastroenterol 1993, 88:1040–1043.

    Google Scholar 

  10. Bechi P, Pucciani F, Baldini F, et al.: Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 1993, 38:1297–1306.

    PubMed  Article  CAS  Google Scholar 

  11. Vaezi MF, Lacamera RG, Richter JE: Validation studies of Bilitec 2000; an ambulatory duodenogastric reflux monitoring system. Am J Physiology 1994, 267:G1050-G1057.

    CAS  Google Scholar 

  12. Vaezi MF, Richter JE: Role of acid and duodenogastric reflux in gastroesophageal reflux disease. Gastroenterology 1996, 111:1192–1199.

    PubMed  Article  CAS  Google Scholar 

  13. Marshall RE, Anggiansah A, Owen WA, Owen WJ: The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997, 40:182–187.

    PubMed  CAS  Article  Google Scholar 

  14. Vaezi MF, Richter JE: Contribution of acid and DGER to oesophageal mucosal injury and symptoms in partial gastrectomy patients. Gut 1997, 41:297–302.

    PubMed  CAS  Article  Google Scholar 

  15. Marshall RE, Anggiansah A, Owen WA, Owen WJ: Investigation of oesophageal reflux symptoms after gastric surgery with combined pH and bilirubin monitoring. Br J Surg 1993, 86:271–275.

    Article  Google Scholar 

  16. Wilmer A, Tack J, Frans E, et al.: Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology 1999, 116:1293–1299.

    PubMed  Article  CAS  Google Scholar 

  17. Gut A, Gaia C, Netzer P, et al.: Reduction of esophageal bile and acid reflux by pantoprazole in patients with reflux esophagitis. Gastroenterology 1997, 112:A135.

    Google Scholar 

  18. Marshall RE, Anggiansah A, Manifold DK, et al.: Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett’s oesophagus. Gut 1998, 43:603–606.

    PubMed  CAS  Article  Google Scholar 

  19. KockGH, Sifrim D, Lerut T, et al.: Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gasto-esophageal reflux refractory to proton-pump inhibitors. Gut 2003, 52:1397–1402. Study suggests baclofen, 20 mg three times daily may reduce DGER by inhibiting the occurrence of transient LES relaxation after a meal.

    Article  Google Scholar 

  20. Vaezi MF, Sears R, Richter JE: Placebo-controlled trial of cisapride in postgastrectomy patients with DGER. Dig Dis Sci 1996, 41:754–763.

    PubMed  Article  CAS  Google Scholar 

  21. Malagelada JR, Phillips SF, Shorter RG, et al.: Postoperative reflux gastritis: pathophysiology and long-term outcome after Roux-en-Y diversion. Ann Intern Med 1985, 107:178–183.

    Google Scholar 

  22. Klingler PJ, Perdikis G, Wilson P, Hinder RA: Indications, technical modalities and results of the duodenal switch operation for pathologic duodenogastric reflux. Hepato-Gastroenterology 1999, 46:97–102.

    PubMed  CAS  Google Scholar 

  23. Clain JE, Malagelada JR, Chadwick VS, Hofmann AF: Binding properties in vitro of antacids for conjugated bile acids. Gastroenterology 1977, 73:556–559.

    PubMed  CAS  Google Scholar 

  24. Meshkinpour H, Elashoff J, Stewart H, Sturdevant RA: Effect of cholestyramine on the symptoms of reflux gastritis: a randomized, double-blind, cross-over study. Gastroenterology 1977, 73:441–443.

    PubMed  CAS  Google Scholar 

  25. Scudamore HH, Eckstam EE, Fencil WJ, Jaramillo CA: Bile reflux gastritis. Am J Gastroenterol 1973, 60:9–22.

    PubMed  CAS  Google Scholar 

  26. Herrington JL, Sawyers JL, Whitehead WA: Surgical management of reflux gastritis. Ann Surg 1974, 180:526–537.

    PubMed  Article  Google Scholar 

  27. Stafaniwsky AB, Tint GS, Speck J, et al.: Ursodeoycholic acid treatment of bile reflux gastritis. Gastroenterology 1985, 89:1000–1004.

    Google Scholar 

  28. Buch KL, Weinstein WM, Hill TA, et al.: Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. A randomized, double-blind study. Am J Med 1985, 79(suppl 2C):49–54.

    PubMed  Article  CAS  Google Scholar 

  29. Hameeteman W: Clinical studies of sucralfate in reflux esophagitis.J Clin Gastroenterol 1991, 13(suppl 2):S16-S20.

    PubMed  Google Scholar 

  30. Bonavina L, Incarbone R, Segalin A, et al.: Duodenogastro-esophageal reflux after gastric surgery: surgical therapy and outcome in 42 consecutive patients. Hepato-Gastroenterology 1999, 46:92–96.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, 9500 Euclid Avenue, S-40, 44195, Cleveland, OH, USA

    Joel E. Richter MD

Authors
  1. Joel E. Richter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Richter, J.E. Duodenogastric reflux-induced (alkaline) esophagitis. Curr Treat Options Gastro 7, 53–58 (2004). https://doi.org/10.1007/s11938-004-0025-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-004-0025-1

Keywords

  • Cisapride
  • Main Side Effect
  • Main Drug Interaction
  • Sucralfate
  • Bile Reflux